{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:08:16Z","timestamp":1751429296706,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202111010"],"award-info":[{"award-number":["SZSM202111010"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen High-level Hospital Construction Fund"},{"name":"Shenzhen Key Medical Discipline Construction Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04068-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:30:31Z","timestamp":1751355031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-linear relationship between the hepatic steatosis index and glycemic progression: evidence from a large-scale retrospective cohort study in a Chinese population"],"prefix":"10.1186","volume":"25","author":[{"given":"Changchun","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fubing","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4068_CR1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"4068_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cjca.2017.12.030","volume":"34","author":"AK Khetan","year":"2018","unstructured":"Khetan AK, Rajagopalan S. Prediabetes. CAN J CARDIOL. 2018;34(5):615\u201323.","journal-title":"CAN J CARDIOL"},{"issue":"Suppl 1","key":"4068_CR3","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association","year":"2022","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17\u201338.","journal-title":"Diabetes Care"},{"issue":"7","key":"4068_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/dc22-2376","volume":"46","author":"MR Rooney","year":"2023","unstructured":"Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, Magliano DJ, Selvin E. Global prevalence of prediabetes. Diabetes Care. 2023;46(7):1388\u201394.","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"4068_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00394-016-1340-8","volume":"55","author":"IA Macdonald","year":"2016","unstructured":"Macdonald IA. A review of recent evidence relating to sugars, insulin resistance and diabetes. EUR J NUTR. 2016;55(Suppl 2):17\u201323.","journal-title":"EUR J NUTR"},{"issue":"1","key":"4068_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.clnu.2019.01.021","volume":"39","author":"Z Chen","year":"2020","unstructured":"Chen Z, Franco OH, Lamballais S, Ikram MA, Schoufour JD, Muka T, Voortman T. Associations of specific dietary protein with longitudinal insulin resistance, prediabetes and type 2 diabetes: the Rotterdam study. CLIN NUTR. 2020;39(1):242\u20139.","journal-title":"CLIN NUTR"},{"issue":"1","key":"4068_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","volume":"39","author":"K Gariani","year":"2013","unstructured":"Gariani K, Philippe J, Jornayvaz FR. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. DIABETES METAB. 2013;39(1):16\u201326.","journal-title":"DIABETES METAB"},{"issue":"1","key":"4068_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-021-01485-x","volume":"20","author":"X Zheng","year":"2021","unstructured":"Zheng X, Cao C, He Y, Wang X, Wu J, Hu H. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among japanese: a retrospective cohort study using propensity score matching. LIPIDS HEALTH DIS. 2021;20(1):59.","journal-title":"LIPIDS HEALTH DIS"},{"issue":"7","key":"4068_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"4068_CR10","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/ajg.2014.155","volume":"109","author":"PJ Meffert","year":"2014","unstructured":"Meffert PJ, Baumeister SE, Lerch MM, Mayerle J, Kratzer W, Volzke H. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. AM J GASTROENTEROL. 2014;109(9):1404\u201314.","journal-title":"AM J GASTROENTEROL"},{"issue":"1","key":"4068_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12876-023-02717-3","volume":"23","author":"HN Kim","year":"2023","unstructured":"Kim HN, Jeon HJ, Choi HG, Kwon IS, Rou WS, Lee JE, Lee TH, Kim SH, Lee BS, Shin KS, et al. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease. BMC GASTROENTEROL. 2023;23(1):77.","journal-title":"BMC GASTROENTEROL"},{"issue":"3","key":"4068_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11739-012-0875-9","volume":"8","author":"AF Cicero","year":"2013","unstructured":"Cicero AF, D\u2019Addato S, Reggi A, Reggiani GM, Borghi C. Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella heart study. INTERN EMERG MED. 2013;8(3):265\u20137.","journal-title":"INTERN EMERG MED"},{"issue":"1","key":"4068_CR13","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1038\/s41598-025-88314-8","volume":"15","author":"H Zeng","year":"2025","unstructured":"Zeng H, Yu F, Hu H, Han Y, Ye R, Cao C. Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes. Sci Rep. 2025;15(1):4269.","journal-title":"Sci Rep"},{"key":"4068_CR14","doi-asserted-by":"crossref","unstructured":"Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. NUTRIENTS. 2017;9(4).","DOI":"10.3390\/nu9040387"},{"key":"4068_CR15","doi-asserted-by":"crossref","unstructured":"Cai X, Gao J, Liu S, Wang M, Hu J, Hong J, Zhu Q, Tuerxun G, Dang Y, Li N. Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study. DIS MARKERS. 2022;2022:3150380.","DOI":"10.1155\/2022\/3150380"},{"issue":"1","key":"4068_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40001-025-02354-4","volume":"30","author":"J Wu","year":"2025","unstructured":"Wu J, Chen Q, Zou JZ, Chen YY, Chen HH, Lin YY, Huang XD. Association between hepatic steatosis index and glucose status conversion from impaired fasting glucose base on Chinese adults: a cohort study from real-world. EUR J MED RES. 2025;30(1):100.","journal-title":"EUR J MED RES"},{"issue":"9","key":"4068_CR17","doi-asserted-by":"publisher","first-page":"c110","DOI":"10.1210\/jendso\/bvac110","volume":"6","author":"T Aizawa","year":"2022","unstructured":"Aizawa T, Nakasone Y, Murai N, Oka R, Nagasaka S, Yamashita K, Sakuma T, Kiyosawa K. Hepatic steatosis and High-Normal fasting glucose as risk factors for incident prediabetes. J Endocr Soc. 2022;6(9):c110.","journal-title":"J Endocr Soc"},{"issue":"1","key":"4068_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12916-023-02818-6","volume":"21","author":"P Wu","year":"2023","unstructured":"Wu P, Wang Y, Ye Y, Yang X, Huang Y, Ye Y, Lai Y, Ouyang J, Wu L, Xu J, et al. Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women. BMC MED. 2023;21(1):150.","journal-title":"BMC MED"},{"key":"4068_CR19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.2147\/DMSO.S462459","volume":"17","author":"R Si","year":"2024","unstructured":"Si R, Xiao J, Zheng K, Yin Y, Li Y. Association between the hepatic steatosis index and risk of incident type 2 diabetes mellitus in the normoglycemic population:a longitudinal prospective study in Japan. Diabetes Metab Syndr Obes. 2024;17:2317\u201326.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4068_CR20","doi-asserted-by":"crossref","unstructured":"Khan R, Chua Z, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to diabetes: diagnosis, treatments and translational research. Med (KAUNAS) 2019, 55(9).","DOI":"10.3390\/medicina55090546"},{"issue":"9","key":"4068_CR21","doi-asserted-by":"publisher","first-page":"e21768","DOI":"10.1136\/bmjopen-2018-021768","volume":"8","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang XP, Yuan J, Cai B, Wang XL, Wu XL, Zhang YH, Zhang XY, Yin T, Zhu XH, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ OPEN. 2018;8(9):e21768.","journal-title":"BMJ OPEN"},{"issue":"4","key":"4068_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. STAT MED. 2011;30(4):377\u201399.","journal-title":"STAT MED"},{"issue":"11","key":"4068_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1503\/cmaj.110977","volume":"184","author":"RH Groenwold","year":"2012","unstructured":"Groenwold RH, White IR, Donders AR, Carpenter JR, Altman DG, Moons KG. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012;184(11):1265\u20139.","journal-title":"CMAJ"},{"issue":"1","key":"4068_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-020-01409-1","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Zheng R, Li J, Feng S, Wang L, Huang Z. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. LIPIDS HEALTH DIS. 2020;19(1):229.","journal-title":"LIPIDS HEALTH DIS"},{"issue":"12","key":"4068_CR25","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. INT J SURG. 2014;12(12):1495\u20139.","journal-title":"INT J SURG"},{"issue":"14","key":"4068_CR26","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.7150\/ijms.62010","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Cai Z, Deng X, Li H, Zhao Z, Guo C, Zhang P, Li L, Gu T, Yang L, et al. Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes. INT J MED SCI. 2021;18(14):3280\u20139.","journal-title":"INT J MED SCI"},{"key":"4068_CR27","doi-asserted-by":"crossref","unstructured":"Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Sakamoto K, Azuma M, Kokaze A. Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan. DIS MARKERS. 2021;2021:9941834.","DOI":"10.1155\/2021\/9941834"},{"issue":"1","key":"4068_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-020-01025-4","volume":"19","author":"JH Kim","year":"2020","unstructured":"Kim JH, Moon JS, Byun SJ, Lee JH, Kang DR, Sung KC, Kim JY, Huh JH. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study. CARDIOVASC DIABETOL. 2020;19(1):51.","journal-title":"CARDIOVASC DIABETOL"},{"issue":"2","key":"4068_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","volume":"49","author":"KM Gavin","year":"2020","unstructured":"Gavin KM, Bessesen DH. Sex differences in adipose tissue function. Endocrinol Metab Clin North Am. 2020;49(2):215\u201328.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"4068_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","volume":"1043","author":"BT Palmisano","year":"2017","unstructured":"Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism. ADV EXP MED BIOL. 2017;1043:227\u201356.","journal-title":"ADV EXP MED BIOL"},{"issue":"10","key":"4068_CR31","doi-asserted-by":"publisher","first-page":"E1188","DOI":"10.1152\/ajpendo.00579.2013","volume":"306","author":"L Zhu","year":"2014","unstructured":"Zhu L, Martinez MN, Emfinger CH, Palmisano BT, Stafford JM. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am J Physiol Endocrinol Metab. 2014;306(10):E1188\u201397.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"4068_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1159\/000521662","volume":"40","author":"LY Kam","year":"2022","unstructured":"Kam LY, Huang DQ, Teng M, Takahashi H, Tanaka K, Yasuda S, Fung J, Lee TY, Hyogo H, Ono M, et al. Clinical profiles of Asians with NAFLD: A systematic review and Meta-Analysis. Dig Dis. 2022;40(6):734\u201344.","journal-title":"Dig Dis"},{"issue":"9","key":"4068_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.15537\/smj.2023.44.9.20230021","volume":"44","author":"J Zhang","year":"2023","unstructured":"Zhang J, Huang X, Dong L, Yang Y, Kong D. Epidemiology of lean\/non-obese nonalcoholic fatty liver disease in china: A systematic review and meta-analysis. SAUDI MED J. 2023;44(9):848\u201363.","journal-title":"SAUDI MED J"},{"issue":"1","key":"4068_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep4.1143","volume":"2","author":"LB VanWagner","year":"2018","unstructured":"VanWagner LB, Armstrong MJ. Lean NAFLD: A not so benign condition? Hepatol Commun. 2018;2(1):5\u20138.","journal-title":"Hepatol Commun"},{"issue":"1","key":"4068_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstrom","year":"2018","unstructured":"Hagstrom H, Nasr P, Ekstedt M, Hammar U, Stal P, Hultcrantz R, Kechagias S. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. Hepatol Commun. 2018;2(1):48\u201357.","journal-title":"Hepatol Commun"},{"issue":"18","key":"4068_CR36","doi-asserted-by":"publisher","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","volume":"96","author":"H Yoshitaka","year":"2017","unstructured":"Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. Med (Baltim). 2017;96(18):e6712.","journal-title":"Med (Baltim)"},{"issue":"2","key":"4068_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/liv.12912","volume":"36","author":"T Fukuda","year":"2016","unstructured":"Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. LIVER INT. 2016;36(2):275\u201383.","journal-title":"LIVER INT"},{"key":"4068_CR38","doi-asserted-by":"crossref","unstructured":"Caprio S, Pierpont B, Kursawe R. The adipose tissue expandability hypothesis: a potential mechanism for insulin resistance in obese youth. HORM MOL BIOL CLIN INVESTIG 2018, 33(2).","DOI":"10.1515\/hmbci-2018-0005"},{"issue":"5","key":"4068_CR39","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371.","journal-title":"Cell"},{"key":"4068_CR40","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, Luo M. Association of inflammatory cytokines with Non-Alcoholic fatty liver disease. FRONT IMMUNOL. 2022;13:880298.","journal-title":"FRONT IMMUNOL"},{"key":"4068_CR41","doi-asserted-by":"crossref","unstructured":"Ziolkowska S, Binienda A, Jablkowski M, Szemraj J, Czarny P. The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease. INT J MOL SCI 2021, 22(20).","DOI":"10.3390\/ijms222011128"},{"issue":"7121","key":"4068_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"key":"4068_CR43","doi-asserted-by":"publisher","first-page":"595371","DOI":"10.3389\/fmed.2021.595371","volume":"8","author":"BA Delli","year":"2021","unstructured":"Delli BA, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative stress in Non-alcoholic fatty liver disease. An updated Mini review. Front Med (Lausanne). 2021;8:595371.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04068-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04068-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04068-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:30:35Z","timestamp":1751355035000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04068-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4068"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04068-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original study was approved by the Rich Healthcare Group Review Board, which waived the requirement for informed consent. No additional approval from the institutional review board was necessary for the secondary analysis. This study was conducted in accordance with the principles outlined in the Declaration of Helsinki, ensuring compliance with all relevant ethical guidelines and regulatory standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"484"}}